Abstract:Eimeria infection impacts upon chicken welfare and economic productivity of the poultry sector. Live coccidiosis vaccines for chickens have been available for almost 70 years, but the requirement to formulate blends of oocysts from multiple Eimeria species makes vaccine production costly and logistically demanding. A multivalent vaccine that does not require chickens for its production and can induce protection against multiple Eimeria species is highly desirable. However, despite the identification and testing of many vaccine candidate antigens, no recombinant coccidiosis vaccine has been developed commercially. Currently, assessment of vaccine efficacy against Eimeria, and the disease coccidiosis, can be done only through in vivo vaccination and challenge experiments but the design of such studies has been highly variable. Lack of a "standard" protocol for assessing vaccine efficacy makes comparative evaluations very difficult, complicating vaccine development, and validation. The formulation and schedule of vaccination, the breed of chicken and choice of husbandry system, the species, strain, magnitude, and timing of delivery of the parasite challenge, and the parameters used to assess vaccine efficacy all influence the outcomes of experimental trials. In natural Eimeria infections, the induction of strong cell mediated immune responses are central to the development of protective immunity against coccidiosis. Antibodies are generally regarded to be of lesser importance. Unfortunately, there are no specific immunological assays that can accurately predict how well a vaccine will protect against coccidiosis (i.e., no "correlates of protection"). Thus, experimental vaccine studies rely on assessing a variety of post-challenge parameters, including assessment of pathognomonic lesions, measurements of parasite replication such as oocyst output or quantification of Eimeria genomes, and/or measurements of productivity such as body weight gain and feed conversion rates. Understanding immune responses to primary and secondary infection can inform on the most appropriate immunological assays. The discovery of new antigens for different Eimeria species and the development of new methods of vaccine antigen delivery necessitates a more considered approach to assessment of novel vaccines with robust, repeatable study design. Careful consideration of performance and welfare factors that are genuinely relevant to chicken producers and vaccine manufacturers is essential.

Coccidia: A review of recent advances on immunity and vaccine development

Coccidiosis: Recent Progress in Host Immunity and Alternatives to Antibiotic Strategies

Recent Advances in Biology and Immunobiology of Eimeria Species and in Diagnosis and Control of Infection with These Coccidian Parasites of Poultry

Past and future: vaccination against Eimeria

A comprehensive overview of coccidiosis in chicken

Poultry Coccidiosis: Design and Interpretation of Vaccine Studies

Avian gut-associated immune system: implication in coccidial vaccine development.

Spotlight on avian pathology: Eimeria and the disease coccidiosis

Exploring Eimeria Genomes to Understand Population Biology: Recent Progress and Future Opportunities

Securing poultry production from the ever-present Eimeria challenge

Diagnosis and control of chicken coccidiosis: a recent update

Molecular characterization and immune protective efficacy of 3 Eimeria tenella antigens

The role of intestinal intraepithelial lymphocytes in resistance against coccidiosis in chickens

Understanding the interactions between Eimeria infection and gut microbiota, towards the control of chicken coccidiosis: a review

Live attenuated anticoccidial vaccines for chickens

Innovative prevention and control of coccidiosis: targeting sporogony for new control agent development

Genetic selection of Eimeria parasites in the chicken for improvement of poultry health: implications for drug resistance and live vaccine development

Evaluation of a coccidia vaccine using spray and gel applications

Prevalence of Avian coccidiosis in India: a review

Vaccination Against Poultry Parasites

What Do We Know about Surface Proteins of Chicken Parasites Eimeria?